In line with Hepatitis Awareness Month, we spoke to Marcus Dorner about his current research into the host–virus interactions in hepatitis B and C infection, their implications for vaccine development and more.
Browsing: Clinical > Vaccines
In this exclusive opinion piece, the authors discuss how a neuroattenuated varicella zoster virus (VZV) vaccine could provide promising protection against VZV infection.
In this systematic review from Future Microbiology the author assesses data of Phase I–III trials including malaria-naive adults and adults, children and infants from malaria endemic settings in sub-Saharan Africa.
John-Arne Røttingen discusses his role as founding CEO of the Coalition for Epidemic Preparedness Innovations (CEPI) and his thoughts on the importance of developing new vaccines for emerging threats.
Despite challenges and setbacks in the decades-long struggle to eradicate polio, effective vaccines, evidence-based policy and global cooperation have brought the world closer to achieving polio eradication than ever before.
In new research, the first live-attenuated Zika vaccine has been demonstrated to protected mice against the virus after a single dose.
Oral delivery of vaccines is an attractive approach but is hampered by a number of challenges. Here, the authors discuss the need to include immunostimulatory adjuvants in oral vaccines to overcome oral tolerance and elicit effector immune responses locally within the intestine.
New research suggests that maternal vaccination may be the most effective strategy for preventing pertussis in infants throughout the first year of life.